2016
DOI: 10.1371/journal.pone.0162589
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial

Abstract: ObjectiveThis multicenter, randomized, placebo-controlled study evaluated the efficacy and side effects of parecoxib during patient-controlled epidural analgesia (PCEA) after abdominal hysterectomy.MethodsA total of 240 patients who were scheduled for elective abdominal hysterectomy under combined spinal-epidural anesthesia received PCEA plus postoperative intravenous parecoxib 40 mg or saline every 12 h for 48 h after an initial preoperative dose of parecoxib 40 mg or saline. An epidural loading dose of a mix… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 47 publications
1
5
0
Order By: Relevance
“…However, since no previous studies have been conducted comparing the impact of PCA and parecoxib, on daily activities no direct comparison of results is therefore possible. Notwithstanding, the positive effect of parecoxib use on physical activity observed in this study was consistent with findings of earlier reports, and adds to the growing body of literature on this topic ( 10 , 21 ). It is well known that morphine, or other opioids, is the most widely used intravenous drug for PCA, even as these common medications may be related to several adverse effects, such as nausea, vomiting, respiratory depression, sedation, constipation, confusion and urinary retention ( 8 , 9 ).…”
Section: Discussionsupporting
confidence: 93%
“…However, since no previous studies have been conducted comparing the impact of PCA and parecoxib, on daily activities no direct comparison of results is therefore possible. Notwithstanding, the positive effect of parecoxib use on physical activity observed in this study was consistent with findings of earlier reports, and adds to the growing body of literature on this topic ( 10 , 21 ). It is well known that morphine, or other opioids, is the most widely used intravenous drug for PCA, even as these common medications may be related to several adverse effects, such as nausea, vomiting, respiratory depression, sedation, constipation, confusion and urinary retention ( 8 , 9 ).…”
Section: Discussionsupporting
confidence: 93%
“…Parecoxib is used mostly for short-term perioperative pain control, and a recent clinical trial reported that pre-emptive administration of parecoxib can significantly reduce the risk of ipsilateral shoulder pain after thoracotomy. 4 Although the efficacy of pre-emptive analgesia with intravenous parecoxib has been well described, [4][5][6][7][8][9] its correlation with the Strengths and limitations of this study ► Latent curve analysis revealed the complex relationship between dynamic changes of postoperative pain scores over time, various types of analgesic modalities and patient characteristics in the clinical setting of video-assisted thoracoscopic surgery. ► It is noted that parecoxib mainly exerted its preemptive analgesic effects on the baseline value rather than decreasing rate of postoperative pain scores.…”
Section: Introductionmentioning
confidence: 99%
“…Parecoxib is used mostly for short-term perioperative pain control, and a recent clinical trial reported that pre-emptive administration of parecoxib can significantly reduce the risk of ipsilateral shoulder pain after thoracotomy 4. Although the efficacy of pre-emptive analgesia with intravenous parecoxib has been well described,4–9 its correlation with the postoperative pain trajectories over time has not been established.…”
Section: Introductionmentioning
confidence: 99%
“…Adjunctive parecoxib during morphine combined with ropivacaine epidural PCA (PCEA) following abdominal hysterectomy is safe and efficacious in reducing pain [9]. e combination of dexmedetomidine and sufentanil for intravenous PCA (PCIA) after abdominal operation could reduce sufentanil consumption, decrease visual analogue scale (VAS) scores, lower the rate of nausea and vomiting, and improve patient satisfaction [10].…”
Section: Introductionmentioning
confidence: 99%